The clinical alarm management market is set to grow by USD 2,393.76 million from 2022 to 2027. The market is estimated…
Category: Insights
Antivenoms Global Market Report 2023: Sector to Reach $2.3 Billion by 2030 at a 7.4% CAGR
In the changed post COVID-19 business landscape, the global market for Antivenoms estimated at US$1.3 Billion in the…
APAC Pharmaceutical Packaging Market Report 2023: Sector to Reach $22.81 Billion by 2028 at a 5% CAGR
The “APAC Pharmaceutical Packaging Market – Focused Insights 2023-2028”report has been added to ResearchAndMarkets.com’s offering. This report offers market…
Physician’s Plan Offers Revolutionary Weight Loss Medication Semaglutide to Patients in North and South Carolina
Physician’s Plan, a leader in medical weight loss, is excited to provide its patients with Semaglutide,…
Endel and Universal Music Group to Create AI-Powered, Artist-Driven Functional Music, Designed to Support Listener Wellness
AI sound wellness company, Endel, and Universal Music Group (UMG), the world leader in music-based entertainment,…
AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery
AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to…
Sobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced that it has commenced a tender offer…
Biochips Market size is set to grow by USD 43,273.01 million from 2022 to 2027; The growing use of personalized medicines to boost the market – Technavio
The global biochips market size is estimated to grow by USD 43,273.01 million from 2022 to 2027, according to Technavio. The…
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products
Kelyniam Global (OTC: KLYG), a leading maker of custom cranial implants, today announced results for its quarter ended March 31, 2023. “I’m pleased to announce that…
Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic
BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that they have submitted a Marketing Authorisation…